30 Participants Needed

Intensive Bimanual Therapy for Cerebral Palsy

CM
Overseen ByCatherine Mercier, PhD;OT
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Laval University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Motor disorders related to cerebral palsy are often accompanied by sensory, cognitive, perceptive, communication and behavioural impairments. It has already been shown that intensive bimanual intervention can improve arm movement, but its impact on the spontaneous use of the most affected arm in everyday life remains to be established. This project aims to understand the impacts of an intensive bimanual therapy on uni- and bi-manual motor functions as well as the spontaneous use of the most affected arm. Predictive value of neuroimaging variables will also be assessed.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have had a Botox injection in the last 4 months, you cannot participate.

Is Intensive Bimanual Therapy safe for humans?

The available research on Intensive Bimanual Therapy, including variations like HABIT and HABIT-ILE, does not report any safety concerns for children with cerebral palsy. These therapies have been studied in various settings and have shown improvements in motor skills without indicating any adverse effects.12345

How is intensive bimanual therapy different from other treatments for cerebral palsy?

Intensive bimanual therapy is unique because it focuses on improving the coordination and use of both hands together, which is different from other treatments that might focus on just one hand. It involves structured practice and problem-solving activities that require both hands to work together, helping children with cerebral palsy improve their motor skills.12467

Eligibility Criteria

This trial is for children with cerebral palsy who can understand and perform study tasks, have sensorimotor deficits in one or both arms (with a preference on one side), and are classified as MACS level 1 to 3. It's not for those with uncorrected vision issues, other major health problems that could interfere, or recent Botox injections in the arms.

Inclusion Criteria

I have been diagnosed with cerebral palsy or spastic hemiparesis.
I have movement difficulties in one or both of my arms.
I can understand and follow the study's tasks.

Exclusion Criteria

Presenting significant uncorrected visual deficits
I do not have any major health issues that could affect my participation.
I have had a Botox injection in my arm(s) within the last 4 months.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-intervention Evaluation

Neuroimaging assessment, clinical evaluation, robotic evaluation, and movement evaluation using inertial control units

1 week

Treatment

Participants undergo a 60-hour intensive bimanual therapy at a day camp, 6 hours/day for 10 days

2 weeks
10 visits (in-person)

Post-intervention Evaluation

Clinical and robotic evaluations, including Jebsen Taylor Test of Hand Function and self-assessments

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment, including neuroimaging and various clinical evaluations

6 months
2 visits (in-person)

Treatment Details

Interventions

  • Intensive bimanual therapy
Trial Overview The trial studies intensive bimanual therapy's effect on arm movement and everyday use of the most affected arm in kids with cerebral palsy. It also looks at how brain imaging might predict outcomes from this therapy.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: MANUSExperimental Treatment1 Intervention
Children and youth living with cerebral palsy will take part in a 60-hour intensive bimanual therapy at Peps at Université Laval, during which they will play games and exercise to promote spontaneous use of the most affected hand. Participants will take part to pre-evaluation and 1-week and 6-month post-intervention.

Intensive bimanual therapy is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Intensive Bimanual Therapy for:
  • Cerebral Palsy
  • Upper Limb Motor Deficits
🇪🇺
Approved in European Union as Hand-Arm Bimanual Intensive Therapy (HABIT) for:
  • Cerebral Palsy
  • Bilateral Cerebral Palsy
  • Upper Limb Motor Deficits
🇨🇦
Approved in Canada as Bimanual Therapy for:
  • Cerebral Palsy
  • Upper Limb Motor Deficits

Find a Clinic Near You

Who Is Running the Clinical Trial?

Laval University

Lead Sponsor

Trials
439
Recruited
178,000+

Findings from Research

HABIT-ILE (Hand Arm Bimanual Intensive Therapy Including Lower Extremities) is a new therapy designed for children with unilateral spastic cerebral palsy, focusing on tasks that require coordination of both upper and lower extremities, which may better address their motor control challenges.
This therapy involves 90 hours of structured practice in small groups, progressively increasing task complexity, but further research through randomized controlled trials is necessary to evaluate its effectiveness.
Hand-arm bimanual intensive therapy including lower extremities (HABIT-ILE) for children with cerebral palsy.Bleyenheuft, Y., Gordon, AM.[2014]
Hand-Arm Bimanual Intensive Therapy (HABIT) significantly improved daily functioning and unimanual dexterity in children with bilateral cerebral palsy, as shown by assessments like the Pediatric Evaluation of Disability Inventory and the Box and Blocks Test, after a 90-hour intervention with 41 participants aged 4 to 16 years.
Despite the improvements in daily functioning and dexterity of the dominant hand, HABIT did not lead to significant changes in bimanual performance or the dexterity of the non-dominant hand, indicating that while HABIT is beneficial, it may not enhance all aspects of motor function equally.
Hand-arm bimanual intensive therapy and daily functioning of children with bilateral cerebral palsy: a randomized controlled trial.Figueiredo, PRP., Mancini, MC., Feitosa, AM., et al.[2021]
A study involving 86 children with unilateral spastic cerebral palsy showed that both Hand-Arm Bimanual Intensive Therapy (HABIT) and the new HABIT-ILE, which includes lower extremity engagement, led to significant improvements in upper extremity function without diminishing the benefits of the therapy.
HABIT-ILE resulted in larger functional improvements in daily living activities that require coordination between the upper and lower extremities, suggesting that incorporating lower extremity practice can enhance overall therapy outcomes.
Including a Lower-Extremity Component during Hand-Arm Bimanual Intensive Training does not Attenuate Improvements of the Upper Extremities: A Retrospective Study of Randomized Trials.Saussez, G., Brandão, MB., Gordon, AM., et al.[2020]

References

Hand-arm bimanual intensive therapy including lower extremities (HABIT-ILE) for children with cerebral palsy. [2014]
Hand-arm bimanual intensive therapy and daily functioning of children with bilateral cerebral palsy: a randomized controlled trial. [2021]
Including a Lower-Extremity Component during Hand-Arm Bimanual Intensive Training does not Attenuate Improvements of the Upper Extremities: A Retrospective Study of Randomized Trials. [2020]
Efficacy of constraint-induced movement therapy and bimanual training in children with hemiplegic cerebral palsy in an educational setting. [2015]
Preschool HABIT-ILE: study protocol for a randomised controlled trial to determine efficacy of intensive rehabilitation compared with usual care to improve motor skills of children, aged 2-5 years, with bilateral cerebral palsy. [2021]
Intensive upper- and lower-extremity training for children with bilateral cerebral palsy: a quasi-randomized trial. [2017]
Comparing Unimanual and Bimanual Training in Upper Extremity Function in Children With Unilateral Cerebral Palsy. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security